• CBC is non-psychoactive — it does not produce a high on its own.

• CBC is a minor cannabinoid — one of 100+ compounds in the cannabis plant.

• CBC differs from CBD — it interacts with the body through different receptor pathways.

• CBC occurs in full-spectrum products — often found alongside THC and CBD.

• Ask a RISE associate — staff can help identify CBC-containing products at your location.

CBC, short for cannabichromene, is a non-psychoactive minor cannabinoid found in the cannabis plant. It's one of the most abundant cannabinoids in cannabis alongside THC and CBD, even though most commercial flower carries it at lower concentrations than the headline two.

The CBC compound shares a chemical lineage with both THC and CBD. All three start as CBGA — the so-called "mother cannabinoid" — before plant enzymes route them down separate biosynthetic paths. Cannabichromene was first isolated in 1966 by Y. Gaoni and Dr. Raphael Mechoulam and has been a quiet feature of cannabis chemistry ever since.

CBC in weed sits in the "minor cannabinoid" group alongside CBG and CBN, meaning it shows up at lower concentrations, not that it's actually rare. But recently, the CBC cannabinoid is stepping out of the shadows and getting recognized not just as a minor player, but as a key component in cannabis' lineup that interacts with human receptors.

That receptor profile is where the CBC compound starts to take shape as its own thing.

CBC does not produce psychoactive effects on its own. Cannabichromene binds only weakly to the CB1 receptor — the receptor responsible for THC's intoxicating high — so even concentrated CBC won't deliver the buzz a THC product would. The CBC compound is among the non-psychoactive cannabinoids alongside CBD, CBG, and a few others in the same family.

A small distinction worth knowing: "non-psychoactive" and "non-intoxicating" aren't quite the same claim. Research has documented subtle effects of CBC on mood and the central nervous system through indirect pathways, which is why "non-intoxicating" is the more precise term in scientific contexts. The practical answer remains the same — the CBC cannabinoid won't impair you, alter your perception, or affect your ability to drive or work.

Combining CBC with THC will affect how the THC feels, since the two layer through different mechanisms, like the entourage effect, inside a full-spectrum product. As with all cannabis products, individual responses vary — a RISE associate can walk through cannabinoid ratios that match how you actually want to feel.

That non-psychoactive mechanism is also what shapes CBC's broader effects on the body.

What CBC does is interact with the body's endocannabinoid system through CB2 receptors and the TRP family of ion channels rather than through direct CB1 binding. The CBC compound acts as a partial agonist at CB2 — receptors concentrated in immune tissue and peripheral organs — and activates TRPA1 and TRPV1, ion channels involved in how the body picks up temperature, pressure, and chemical signals [Source].

Cannabichromene also slows the breakdown of anandamide, one of the body's natural endocannabinoids. By extending anandamide's activity in the system, CBC participates indirectly in endocannabinoid signaling beyond just its receptor binding.

The cannabichromene effects show up most clearly inside full-spectrum products. Research indicates that CBC effects are typically subtle on their own and amplify when combined with THC, CBD, and the strain's terpene profile — the working theory behind the entourage effect. The CBC terpene interaction, particularly with caryophyllene (which also engages CB2), is part of why full-spectrum products feel different from single-cannabinoid isolates.

How CBC affects the body feeds directly into the wellness benefits the cannabinoid is most often associated with.

What is CBC good for? Some of CBC uses include: supporting the body’s inflammation response, helping regulate discomfort signals, supporting endocannabinoid balance, and showing early promise in skin oil balance. CBC benefits are not as widely known as CBD or THC, mostly because CBC cannabinoid properties have spent less time in the spotlight. Research is catching up, though, and the studies so far give us a clearer sense of where this minor cannabinoid fits in the bigger cannabis picture.

• CBC supports the body’s inflammatory response: CBC activates TRPA1 and TRPV1 channels, which are involved in how the body processes heat, irritation, and inflammatory signals. It also interacts with CB2 receptor activity, a receptor pathway found largely in immune tissues and peripheral organs. That receptor profile is why CBC is often discussed in research around inflammation response rather than intoxication. [Source]

• Cannabichromene interacts with comfort-related sensory pathways: Another CBC cannabinoid benefit. Continuing from the previous point, TRPA1 and TRPV1 channels are also a part of the body’s pain and sensory response system. These channels help the body process signals tied to heat, irritation, and physical stress. Unlike THC, CBC does not rely on strong CB1 activation, so its effect is tied to body signaling rather than intoxication. [Source]

• The CBC cannabinoid helps extend endocannabinoid activity: Anandamide is one of the body’s naturally produced endocannabinoids, often involved in mood, appetite, and internal balance signaling. CBC slows the breakdown of anandamide, which allows this endocannabinoid to remain active longer in the system. This gives CBC an indirect role in endocannabinoid tone beyond simple receptor binding. [Source]

• CBC is studied for skin-balance pathways: CBC has been tested on human skin cells connected to oil production. In that lab study, researchers looked at how non-intoxicating cannabinoids like CBC affected excess oil and inflammation-related skin activity. CBC reduced excess oil activity in those cells, which points to a possible role in helping balance oily skin. [Source]

• The CBC marijuana cannabinoid for brain-cell health: CBC has been studied for its effect on neural stem progenitor cells, which help support healthy brain function. In that research, CBC increased the viability of these cells, making brain-cell health one of the more interesting areas of CBC research. [Source]

• Cannabichromene and mood support: CBC has shown mood-related activity in early cannabinoid research. The strongest way to frame this is that CBC may play a role in mood support, especially as part of a broader cannabinoid profile with THC, CBD, and other plant compounds. [Source]

• CBC has shown antibacterial and antifungal activity in lab research: CBC has been tested against certain bacteria and fungi in lab settings. The findings show that CBC has antimicrobial activity, which makes it another research area worth noting when discussing CBC’s wider potential. [Source]

CBC’s benefits are easiest to understand when you look at how differently it behaves from the cannabinoids most shoppers already know. It helps to put CBC next to CBD and THC and see where each one actually stands.

CBC, CBD, and THC all start at the same molecular fork, a precursor compound called CBGA, before plant enzymes route them down separate paths. They share a chemical lineage and end up doing very different things in the body. Here's how CBC vs CBD vs THC stack up across the points that matter most.

You can also learn more in our “What are cannabinoids?” guide.

Which Cannabinoid Has the Most Research Behind It?

• CBD: Cannabidiol has the deepest research bench of the three. Thousands of published studies, the most extensive human clinical literature behind it, and the widest consumer recognition — most shoppers have already heard of CBD before they ever step into a dispensary [Source].

• THC: With THC, the volume runs even higher. Decades of pharmacology work mapping its effects on perception, appetite, and mood, plus a dominant position in modern commercial flower and concentrates that keeps tetrahydrocannabinol under regulators' microscope more than any other cannabinoid in the plant [Source].

• CBC: On the other side of the research spectrum sits cannabichromene — the cannabinoid that's only recently started pulling serious scientific attention. Animal and cellular work on the CBC compound is accumulating quickly, and researchers are openly calling for human studies to fill in the gaps [Source].

How Do CBC, CBD, and THC Work in the Body?

• CBD: Cannabidiol's main target sits outside the cannabinoid receptor family entirely. It primarily engages the 5-HT1A serotonin receptor and only modulates CB1 and CB2 indirectly, without binding tightly to either one [Source].

• THC: Tetrahydrocannabinol takes the most direct route. It binds CB1 head-on, and that direct activity is the source of the high — along with the appetite shifts, perceptual changes, and short-term memory effects that come along with it [Source].

• CBC: Cannabichromene goes a third direction altogether. It acts at CB2 rather than CB1, and adds activity at the TRPA1 and TRPV1 ion channels — sensors involved in how the body picks up temperature, pressure, and chemical signals. That dual mechanism is part of why CBC behaves so differently from its better-known cousins [Source].

Which Cannabinoid Will Get You High?

• THC: Tetrahydrocannabinol is the intoxicating one. THC produces euphoria, altered perception, and the effects most people picture when they hear "high" — and dose plays a major role in how strong the experience feels.

• CBD: Cannabidiol won't get you high. Its serotonin-pathway activity influences mood and the central nervous system without producing impairment, which is part of why CBD shows up so often in daytime products.

• CBC: The CBC compound also leaves your headspace alone. Cannabichromene contributes effects through CB2 and the TRP channels without altering perception, which means it can layer into a full-spectrum product alongside THC without amplifying the high [Source].

CBC usually works in the background, but it can still shape a strain’s full-spectrum profile. To find it, you’ll need to look beyond strain names and check the cannabinoid breakdown.

CBC flower strains available at RISE include select full-spectrum products like Animal Face, Dayglow #2 x L’Orange x Rebel Sour, and other flower or vape options with CBC listed in the product’s cannabinoid breakdown.

• Animal Face — Relax: Animal Face is an Indica-dominant strain with citrusy, sugary, nutty, earthy, and pine notes. Its CBC content has appeared around 1.2%, alongside terpenes like myrcene, caryophyllene, and limonene.

• Dayglow #2 x L’Orange x Rebel Sour — Energize: For a brighter CBC-containing option, Dayglow #2 x L’Orange x Rebel Sour leans into sharp citrus, sour fruit, and tangy flavor. This Sativa-dominant blend has shown CBC levels around 1.38%, making it one of the stronger CBC picks on this list.

• Julius Caesar — Relax: Julius Caesar brings CBC into a full-spectrum vape format rather than traditional flower. The profile is earthy and pine-forward, with an Indica strain base and CBC levels that have appeared between 0.26% and 0.54% depending on the batch.

• Balance — Hybrid Mix: Balance is the lightest CBC example here, with CBC levels around 0.16% in a full-spectrum Hybrid vape. The flavor profile moves through earth, sweetness, citrus, and pine, giving shoppers another way to find CBC outside flower.

Finding CBC in flower starts with the label, but flower is only one way CBC shows up in cannabis. Because CBC appears in full-spectrum products, you can also find it in formats like vapes, concentrates, tinctures, and other cannabinoid-rich options.

CBC is usually used through full-spectrum cannabis products, not as a standalone cannabinoid. You’ll most often find it in formats where CBC appears alongside THC, CBD, terpenes, and other minor cannabinoids.

• Flower is the unfiltered version. Combustion or vaporization activates CBC alongside THC, CBD, and the strain's full terpene profile. Lowest CBC concentrations of the three formats, but the most intact entourage. To learn more about flower, check out our “cannabis flower guide”.

• Vapes hinge on the COA. Live resin and live rosin cartridges retain measurable CBC; THC-distillate carts often strip the minor cannabinoids out during refining. Read the label before you pay.

• Concentrates split along the same fault line. Solventless extracts like live rosin and hash keep CBC intact; distillate-based concentrates don't.

If the label only shows THC and different types of CBD, the CBC either wasn't measured or fell below the detection threshold.

Sometimes. The answer depends on whether the CBD oil is full-spectrum, broad-spectrum, or isolate. Full-spectrum CBD oil retains the cannabinoids and terpenes from the source hemp, including trace CBC.

Broad-spectrum CBD oil keeps most cannabinoids but removes THC — cannabichromene is usually preserved. CBD isolate is purified to 99%+ CBD, which means the CBC compound and other minor cannabinoids have been removed during processing.

CBC may not be as famous as THC or CBD, but it earns its place in the cannabis conversation. It does not get you high, yet it still plays a role in how full-spectrum products come together, from cannabinoid balance to the way a strain’s profile feels overall.

To shop CBC products at RISE, you can explore for yourself and browse online to compare product details, cannabinoid profiles, and available formats at your own pace. Or stop by your local RISE dispensary and talk with a budtender who can help you find CBC flower and other products that match what you’re looking for.